AM Biotech Wins Prestigious National Innovation Award, Pioneering Bio-Pulsed Exosome Research

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st

AM Biotech Unveils Patented Bio-Pulsed Technology at Industry Forum

AM Bio Tech's "Patented Bio-Pulsed Technology Forum" held on December 15, 2024, successfully concluded. The

AM Biotech joins forces with PITDC to advance biotech innovation and expand into the trillion-dollar pharmaceutical market.

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology

AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global

Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer

AM Biotech’s Unique Bio-pulsed Exosome, Backed by Patents, Shows Bright Prospects in the Global Market

Chairman of AM Biotech, shared the strategic layout of the “bio-pulse induced exosome Technology Platform.”

Chairman of AM Biotech Went to The 49th Annual Meeting of Taiwanese Dermatological Association (TDA) to Give A Special Lecture

Special Lecture at the 2024 Taiwan Dermatology Annual Conference. Discussing the efficiency and mechanism of

Bio-Pulsed Exosome with innovative patented technology from AM Biotech to restore health and beauty

Ascension Medical Biotechnology company(AM Biotech) from Taiwan focusing on the research and development of induced

The Key to Skin Repair: The Fantastic Bio-Pulsed Exosomes

Ascension Medical Biotechnology Co., Ltd. (abbreviation: AM BioTech) is the first in Taiwan and the

The Emergent Role of Exosome Therapy in 2021

Exosomes are extracellular vesicles (EV) derived from endosomes, ranging in size from 30nm to 150nm.

error: Content is protected !!